HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
BAL-ARI8
Also Known As:
7-fluoro-2-(N-methyl-N-carboxymethyl)sulfamoyl xanthone
Networked:
1
relevant articles (
0
outcomes,
0
trials/studies)
Bio-Agent Context: Research Results
Heterocyclic Compounds: 198
Fused-Ring Heterocyclic Compounds
3-Ring Heterocyclic Compounds
Xanthenes: 65
Xanthones: 211
BAL-ARI8: 1
Related Diseases
1.
Diabetes Complications
11/01/1991 - "
These results suggest that BAL-ARI8 may represent a therapeutic approach for the management of diabetic complications.
"
11/01/1991 - "
The effects of a new aldose reductase inhibitor, 7-fluoro-2-(N-methyl-N-carboxymethyl)sulfamoyl xanthone (BAL-ARI8, CAS 124066-40-6), on the diabetic complications of streptozotocin-induced diabetic rats were studied.
"
2.
Cataract (Cataracts)
11/01/1991 - "
The incidence of cataract formation was also reduced, being detected in only 45% of BAL-ARI8 treated animals, against the 100% of diabetic controls showing cataract after 8 weeks from diabetes onset.
"
Related Drugs and Biologics
1.
Streptozocin (Streptozotocin)
2.
Aldehyde Reductase (Aldose Reductase)